Announcement

Certara Brings Chemaxon Cheminformatics Natively to Python with New Python API

Certara launches the Chemaxon Python API: native molecular conversion, property calculation, fingerprinting, and similarity search…

CertaraJuly 20, 2026

On-Demand Webinar

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

Watch this on-demand Q&A on using mechanistic modeling to assess feasibility and prioritize biotherapeutic candidates…

CertaraJuly 17, 2026

On-Demand Webinar

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Learn how dosimetry, clinical pharmacology, pharmacometrics, QSP, and regulatory strategy support dose optimization for therapeutic…

Hunter Stephens, PhDJuly 17, 2026

Blog

Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling

Certara Model Designer brings cloud based pharmacometric modeling to your browser, with a curated model…

Arjen BosJuly 16, 2026

On-Demand Webinar

2026 SEND Explorer Virtual User Group Meeting

–

Danielle PillsburyJuly 16, 2026

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

CertaraJuly 16, 2026

Publication

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…

CertaraJuly 16, 2026

Poster

A Quantitative Systems Pharmacology Comparison Of Tau-targeted Therapeutic Strategies In Alzheimer’s Disease

Certara's quantitative systems pharmacology (QSP) model compares tau-targeted therapeutic strategies in Alzheimer's Disease, including antibodies,…

CertaraJuly 16, 2026

Press Release

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

Danielle PillsburyJuly 15, 2026

Webinar

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Jan ChristophersonJuly 14, 2026

Certara Brings Chemaxon Cheminformatics Natively to Python with New Python API

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling

2026 SEND Explorer Virtual User Group Meeting

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

A Quantitative Systems Pharmacology Comparison Of Tau-targeted Therapeutic Strategies In Alzheimer’s Disease

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Newsletter sign up

Quick links

Solutions

Contact